What is Jackson ImmunoResearch?
Jackson ImmunoResearch is a key player in the life sciences sector, focusing on the production of high-quality secondary antibodies and related reagents. These critical components are indispensable for a wide array of laboratory techniques, including ELISA, Western blotting, and FACS. The company's commitment to reliability, stability, and consistency has made its products a staple in research institutions and universities worldwide. By providing researchers with dependable tools, Jackson ImmunoResearch directly contributes to the advancement of biophysical and biochemical studies, enhancing experimental accuracy and outcomes.
How much funding has Jackson ImmunoResearch raised?
Jackson ImmunoResearch has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
What's next for Jackson ImmunoResearch?
The substantial enterprise-level funding and recent strategic investment signal a strong growth phase for Jackson ImmunoResearch. This capital infusion is expected to fuel further expansion of its product lines, enhance its manufacturing capabilities, and potentially broaden its market reach into new research areas or geographical regions. The company's focus on core strengths in antibody production, coupled with strategic backing, positions it for continued leadership and innovation in supplying essential reagents to the global scientific community.
See full Jackson ImmunoResearch company page
